These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8892171)

  • 61. Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study.
    Henry RR; Rosenstock J; Edelman S; Mudaliar S; Chalamandaris AG; Kasichayanula S; Bogle A; Iqbal N; List J; Griffen SC
    Diabetes Care; 2015 Mar; 38(3):412-9. PubMed ID: 25271207
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
    Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
    Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-beta in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats.
    Wigg SJ; Tare M; Forbes J; Cooper ME; Thomas MC; Coleman HA; Parkington HC; O'Brien RC
    Diabetologia; 2004 Jun; 47(6):1038-46. PubMed ID: 15184978
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Study protocol: a randomised placebo-controlled clinical trial to study the effect of vitamin D supplementation on glycaemic control in type 2 Diabetes Mellitus SUNNY trial.
    Krul-Poel YH; van Wijland H; Stam F; ten Boekel E; Lips P; Simsek S
    BMC Endocr Disord; 2014 Jul; 14():59. PubMed ID: 25033925
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Determination of alpha-tocopherol in plasma, platelets and erythrocytes of type I and type II diabetic patients by high-performance liquid chromatography.
    Caye-Vaugien C; Krempf M; Lamarche P; Charbonnel B; Pieri J
    Int J Vitam Nutr Res; 1990; 60(4):324-30. PubMed ID: 2101824
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients.
    Paolisso G; D'Amore A; Galzerano D; Balbi V; Giugliano D; Varricchio M; D'Onofrio F
    Diabetes Care; 1993 Nov; 16(11):1433-7. PubMed ID: 8299431
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Effect of Vitamin D Supplementation on Adiposity, Blood Glycated Hemoglobin, Serum Leptin and Tumor Necrosis Factor-α in Type 2 Diabetic Patients.
    Ghavamzadeh S; Mobasseri M; Mahdavi R
    Int J Prev Med; 2014 Sep; 5(9):1091-8. PubMed ID: 25317290
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chronic intake of pharmacological doses of vitamin E might be useful in the therapy of elderly patients with coronary heart disease.
    Paolisso G; Gambardella A; Giugliano D; Galzerano D; Amato L; Volpe C; Balbi V; Varricchio M; D'Onofrio F
    Am J Clin Nutr; 1995 Apr; 61(4):848-52. PubMed ID: 7702030
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial.
    Huseini HF; Larijani B; Heshmat R; Fakhrzadeh H; Radjabipour B; Toliat T; Raza M
    Phytother Res; 2006 Dec; 20(12):1036-9. PubMed ID: 17072885
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-Term Vitamin D Supplementation Affects Metabolic Status in Vitamin D-Deficient Type 2 Diabetic Patients with Coronary Artery Disease.
    Farrokhian A; Raygan F; Bahmani F; Talari HR; Esfandiari R; Esmaillzadeh A; Asemi Z
    J Nutr; 2017 Mar; 147(3):384-389. PubMed ID: 28122931
    [No Abstract]   [Full Text] [Related]  

  • 71. Treatment for 6 months with fish oil-derived n-3 polyunsaturated fatty acids has neutral effects on glycemic control but improves dyslipidemia in type 2 diabetic patients with abdominal obesity: a randomized, double-blind, placebo-controlled trial.
    Wang F; Wang Y; Zhu Y; Liu X; Xia H; Yang X; Sun G
    Eur J Nutr; 2017 Oct; 56(7):2415-2422. PubMed ID: 27913872
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chronic treatment of African-American type 2 diabetic patients with alpha-glucosidase inhibition.
    Johnston PS; Feig PU; Coniff RF; Krol A; Kelley DE; Mooradian AD
    Diabetes Care; 1998 Mar; 21(3):416-22. PubMed ID: 9540025
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of vitamin D-fortified low fat yogurt on glycemic status, anthropometric indexes, inflammation, and bone turnover in diabetic postmenopausal women: A randomised controlled clinical trial.
    Jafari T; Faghihimani E; Feizi A; Iraj B; Javanmard SH; Esmaillzadeh A; Fallah AA; Askari G
    Clin Nutr; 2016 Feb; 35(1):67-76. PubMed ID: 25794439
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial.
    Witham MD; Dove FJ; Dryburgh M; Sugden JA; Morris AD; Struthers AD
    Diabetologia; 2010 Oct; 53(10):2112-9. PubMed ID: 20596692
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of vitamin C and/or E supplementations on type 2 diabetic adult males under metformin treatment: A single-blinded randomized controlled clinical trial.
    El-Aal AA; El-Ghffar EAA; Ghali AA; Zughbur MR; Sirdah MM
    Diabetes Metab Syndr; 2018 Jul; 12(4):483-489. PubMed ID: 29571976
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
    Florakis D; Hung V; Kaltsas G; Coyte D; Jenkins PJ; Chew SL; Grossman AB; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):453-9. PubMed ID: 11012570
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.
    Hollander PA; Elbein SC; Hirsch IB; Kelley D; McGill J; Taylor T; Weiss SR; Crockett SE; Kaplan RA; Comstock J; Lucas CP; Lodewick PA; Canovatchel W; Chung J; Hauptman J
    Diabetes Care; 1998 Aug; 21(8):1288-94. PubMed ID: 9702435
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial.
    Johansen NJ; Dejgaard TF; Lund A; Schlüntz C; Frandsen CS; Forman JL; Wewer Albrechtsen NJ; Holst JJ; Pedersen-Bjergaard U; Madsbad S; Vilsbøll T; Andersen HU; Knop FK
    Lancet Diabetes Endocrinol; 2020 Apr; 8(4):313-324. PubMed ID: 32135138
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA).
    DeMaio SJ; King SB; Lembo NJ; Roubin GS; Hearn JA; Bhagavan HN; Sgoutas DS
    J Am Coll Nutr; 1992 Feb; 11(1):68-73. PubMed ID: 1541798
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Malondialdehyde (MDA) level in diabetic subjects. Relationship with blood glucose and glycosylated hemoglobin.
    Noberasco G; Odetti P; Boeri D; Maiello M; Adezati L
    Biomed Pharmacother; 1991; 45(4-5):193-6. PubMed ID: 1932603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.